This data continues to suggest that not only is baseline AFP-L3+/DCP+ expression associated with more aggressive HCC biology, but also that sustained expression may be a clear indicator of aggressive residual disease warranting immediate retreatment. Here, AFP is linked to hepatocellular carcinoma.